Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study

BACKGROUND: Preliminary, mostly uncontrolled studies suggest that dose reduction or discontinuation of tumour necrosis factor blockers can be achieved in a relevant proportion of patients with RA without loss of disease control. However, long term safety, cost effectiveness and feasibility in clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: den Broeder, Alfons A, van Herwaarden, Noortje, van der Maas, Aatke, van den Hoogen, Frank HJ, Bijlsma, Johannes W, van Vollenhoven, Ronald F, van den Bemt, Bart JF
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016115/
https://www.ncbi.nlm.nih.gov/pubmed/24152421
http://dx.doi.org/10.1186/1471-2474-14-299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016115/
https://www.ncbi.nlm.nih.gov/pubmed/24152421
http://dx.doi.org/10.1186/1471-2474-14-299

Ejemplares similares